Chemical Compound
Rosiglitazone maleate
CAS Registry Number
155141-29-0
Primary Record
Rosiglitazone maleate
Note: Only for scientific research or as raw materials for production.
- In stock
- 8,771 g
- Purity
- 99.4 %
- CAS
- 155141-29-0
Compound Identifiers & Properties
- CAS
- 155141-29-0
- PubChem CID
- 5281055
- SMILES
- CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=C\C(=O)O)\C(=O)O
- Canonical SMILES
- CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O
Names & Synonyms
- Rosiglitazone maleate
- Avandia
- Avandaryl
- Nyracta
- 155141-29-0
- Rosiglitazone XR
- Venvia
- rosiglitazone
- Avandamet
- Mixture Name
- Rosiglitzazone maleate
- Avandia (TN)
- Rosiglitazone (maleate)
- Rosiglitazonemaleate
- Rosiglitazone Maleate [USAN]
- AC1NQXYB
- RefChem:56530
- BRL 49653C
- BRL-49653C
- maleic acid; rosiglitazone
- DTXSID2023569
- MFCD03427306
- (Z)-but-2-enedioic acid
- CHEMBL843
- D0K5ER
- UNII-KX2339DP44
- BRL 49653-C
- BRL-49653-C
- DTXCID703569
- KX2339DP44
- SCHEMBL19023
- MLS001306472
- MLS001401426
- NSC-717764
- SUFUKZSWUHZXAV-BTJKTKAUSA-N
- CHEBI:8892
- orb1307989
- orb3025111
- C18H19N3O3S.C4H4O4
- SCHEMBL29376790
- C22H23N3O7S
- Rosiglitazone maleate (JAN/USP)
- NSC717764
- GLXC-05178
- HMS2051B11
- HMS2233I10
- HMS3884H04
- HMS5081E15
- Rosiglitazone maleate (JAN/USAN)
- ROSIGLITAZONE MALEATE [MI]
- ROSIGLITAZONE MALEATE [JAN]
- MSK10098
- Rosiglitazone (maleate) (Standard)
- Tox21_302367
- AC-737
- EBC-11276
- HB4140
- HY-14600R
- NP3380
- ROSIGLITAZONE MALEATE [VANDF]
- s2505
- Avandiaadministration for 6-12 weeks
- ROSIGLITAZONE MALEATE [MART.]
- AKOS015961534
- ROSIGLITAZONE MALEATE [USP-RS]
- ROSIGLITAZONE MALEATE [WHO-DD]
- ACN-048754
- Avandia administration for 6-12 weeks
- CCG-100943
- CCG-208126
- CID5281055
- CS-1692
- CS-O-02261
- FR27758
- KS-5027
- NC00193
- NSC 717764
- SB-206846
- SB-210232
- NCGC00255233-01
- 5-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleate
- AN-15585
- BC207045
- BR164376
- CPD000471612
- HY-14600
- Rosiglitazone maleate - Bio-X trade mark
- SAM001246610
- SMR000471612
- ROSIGLITAZONE MALEATE [ORANGE BOOK]
- AB0073096
- LS-173475
- A4302
- CAS-155141-29-0
- NS00076223
- ROSIGLITAZONE MALEATE [USP MONOGRAPH]
- SW197573-4
- C18-H19-N3-O3-S.C4-H4-O4
- D00596
- K-4902
- Z-8295
- EN300-1692904
- 141R290
- A809615
- 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-, (2Z)-2-butenedioate (1:1)
- (+-)-5-(p-(2-(Methyl-2-pyridylamino)ethoxy)benzyl)-2,4-thiazolidinedione maleate (1:1)
- Q27888042
- (2Z)-but-2-enedioic acid; 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione
- (Z)-but-2-enedioic acid;5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
- 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1)
- 122320-73-4
- 2,4-Thiazolidinedione,5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-,(2Z)-2-butenedioate
- 5-[[4-[2-[Methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione maleate
- 5-{[4-({2-[methyl(pyridin-2-yl)amino]ethyl}oxy)phenyl]methyl}-1,3-thiazolidine-2,4-dione (2Z)-but-2-enedioate
- 2, 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1)
- 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
- 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleate
- 5-[4-[2-[N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleate
- 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]phenyl methyl]thiazolidine-2,4-dione maleate
- 5-{4-[2-(Methylpyridin-2-ylamino)ethoxy]benzyl}thiazolidine-2,4-dione maleate
- maleic acid; 5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
- maleic acid;5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
- (+ -)-5-[[4-2-(methyl]-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione,(Z)-2-butenedioate (1:1)
- (+-)-5-((4-(2-(Methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione, (Z)-2-Butenedioate (1:1)
- (+-)-5-[[4-2-(methyl]-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione,(Z)-2-butenedioate (1:1)
- (+/-)-5-(P-(2-(METHYL-2-PYRIDYLAMINO)ETHOXY)BENZYL)-2,4-THIAZOLIDINEDIONE MALEATE (1:1)
- (2Z)-But-2-enedioic acid--5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione (1/1)
- (Z)-but-2-enedioate;2-[4-[(2,4-dioxo-1,3-thiazolidin-3-ium-5-yl)methyl]phenoxy]ethyl-methyl-pyridin-2-ylazanium
- (Z)-but-2-enedioic acid; 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
- 1217260-35-9
- 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1)
- 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1); 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (Z)-2-butenedioate (1:1); 5-[[4-[2-(N-Methyl-N-2-pyridylamino)ethoxy]phenyl]methyl]thiazolidine-2,4-dione maleate; Avandia; BRL 49653C; Rosiglitazone maleate; BRL-49653C; SB214521; SB236833; SB237216; BRL 49653C
- 5-((4-(2-(N-METHYL-N-2-PYRIDYLAMINO)ETHOXY)PHENYL)METHYL)THIAZOLIDINE-2,4-DIONE MALEATE
- 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione; but-2-enedioic acid
- 5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione (2Z)-2-butenedioate